A carregar...
CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
Sixteen female patients with diabetes-associated osteoarthritis (DAOA) participated in an openlabel, randomized, cross-over study. The mean patients’ age was 65.5 (±5.4) years, the patients were obese (mean body mass index, 35.8±5.7 kg/m2 ). They suffered from durable osteoarthritis (14.5±7.6 years)...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Russo |
Publicado em: |
SPb RAACI
2017-05-01
|
Colecção: | Medicinskaâ Immunologiâ |
Assuntos: | |
Acesso em linha: | https://www.mimmun.ru/mimmun/article/view/1219 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|